Reuters UK Business

By Andres Gonzalez and Amy-Jo Crowley LONDON (Reuters) -Online classifieds group Adevinta is exploring the sale of its Spanish business, two sources with knowledge of the talks said, as its private equity owners seek to break-up the company to focus on three main markets and boost returns. Norway’s Adevinta, acquired by a consortium led by …

Adevinta explores sale of its Spanish business as owners pursue break-up, sources say Read More »

By Yamini Kalia and Yadarisa Shabong (Reuters) -British healthcare real estate investor Primary Health Properties (PHP) has offered to buy peer Assura for about 1.68 billion pounds ($2.23 billion), outbidding rival U.S. suitors KKR and Stonepeak Partners. Assura agreed to a 1.61 billion pound takeover bid from private investment firms KKR and Stonepeak Partners in …

Assura takeover battle heats up as UK peer PHP outbids US suitors Read More »

PARIS/FRANKFURT (Reuters) -European Central Bank interest rates may be close to bottoming out but uncertainty was high and the environment was prone to sudden changes that could also alter the policy outlook, ECB policymaker Martins Kazaks said on Friday. The ECB has been cutting interest rates quickly over the past year and the debate over …

ECB may be nearing end of rate cuts but trade war is a risk, policymaker says Read More »

By Victoria Waldersee BERLIN (Reuters) -Volkswagen’s shareholders renewed their criticism of the automaker’s corporate governance on Friday, demanding greater board independence and expressing growing concern over the dominance of the German company’s controlling families. At the carmaker’s virtual annual general meeting, several major investors took aim at CEO Oliver Blume’s dual role as head of …

Volkswagen shareholders demand carmaker reform ‘highly problematic’ governance Read More »

NEW YORK (Reuters) – Bayer Pharmaceuticals’ chief operating officer said the head of the top U.S. drug regulator recently reassured industry executives that the Food and Drug Administration would meet its targets for reviews despite recent job cuts and a restructuring. “We’re looking at an FDA and scientific review staff that is stable, engaged and …

Bayer US head says FDA chief reassured pharma executives of timely reviews Read More »

By Maggie Fick, Jacob Gronholt-Pedersen and Stine Jacobsen COPENHAGEN (Reuters) – Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market. Under Jorgensen’s leadership, Novo Nordisk became a world leader in the lucrative weight-loss drug market, with sky-rocketing sales …

Novo Nordisk ousts CEO after falling behind in weight loss market Read More »